Häuser, W.
Schubert, T.
Scherbaum, N.
Tölle, T.
Article History
First Online: 16 October 2018
Change Date: 5 February 2021
Change Type: Erratum
Change Details: An Erratum to this paper has been published:
Change Details: https://doi.org/10.1007/s00482-020-00518-1
Compliance with ethical guidelines
:
: W. Häuser received fees for one lecture from Grünenthal in the past three years. N. Scherbaum received honoraria (advisory boards, lectures, manuscripts, educational material) from AbbVie, Janssen-Cilag, Lundbeck, Medice, Mundipharma, Reckitt-Benckiser / Indivior, and Sanofi-Aventis in the past three years. T. Tölle received fees for lectures and reimbursement of travel expenses from Pfizer, Lilly, Grünenthal, Mundipharma, Indivior, Janssen and Astellas in the past three years. T. Schubert received a fee for data analysis and lecture honoraria from Indivior in the past three years. N. Scherbaum received honoraria from AbbVie, Janssen-Cilag, Lundbeck, Medice, Mundipharma, Reckitt-Benckiser/Indivior, and Sanofi-Aventis in the past three years. T. Tölle received honoraria for lectures and reimbursement of travel expenses from Pfizer, Lilly, Grünenthal, Mundipharma, Indivior, Janssen and Astellas in the past three years.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: This study used anonymized existing health claim data, and therefore it was exempt from requiring ethical approval and patient informed consent.